These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6782611)

  • 1. Effects of acute or chronic administration of low doses of a dopamine agonist on drinking and locomotor activity in the rat.
    Dourish CT; Cooper SJ
    Psychopharmacology (Berl); 1981; 72(2):197-202. PubMed ID: 6782611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of piribedil and of d-amphetamine on locomotor activity in immature rats.
    Dourish CT; Cooper SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):249-55. PubMed ID: 6539932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ET 495 (piribedil) on water intake in the rat: evidence for a dopaminergic involvement in thirst.
    Dourish CT; Cooper SJ
    Ir J Med Sci; 1978 Aug; 147 Suppl 1():19-23. PubMed ID: 689849
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of a piperazine derivative piribedil, on exploration, locomotor activity and social behaviour in the rat.
    File SE
    Prog Neuropsychopharmacol; 1981; 5(3):245-55. PubMed ID: 7267842
    [No Abstract]   [Full Text] [Related]  

  • 5. Sedation, stereotypy and the inhibition of drinking after administration of ET 495 in the rat [proceedings].
    Cooper SJ; Dourish CT
    Br J Pharmacol; 1979 Jul; 66(3):481P. PubMed ID: 575064
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of the locomotor activity effects of apomorphine and the "atypical dopamine agonists" (piribedil and S3608).
    Offermeier J; van Rooyen JM
    Life Sci; 1986 Mar; 38(10):895-903. PubMed ID: 3081774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of piribedil (ET495) on components of locomotor activity.
    Jenner P; Marsden CD
    Eur J Pharmacol; 1975 Aug; 33(1):211-5. PubMed ID: 1175688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Dopa and piribedil alter different components of attentional behavior dependent on dose.
    Cheal M
    Psychopharmacology (Berl); 1983; 80(4):345-50. PubMed ID: 6414004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of drinking and induction of sedation by a dopamine agonist is blocked by small doses of spiperone.
    Dourish CT; Cooper SJ
    Neuropharmacology; 1982 Jan; 21(1):69-72. PubMed ID: 7199629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of food intake by piribedil in the rat: relation to dopamine receptor stimulation.
    Carruba MO; Ricciardi S; Mantegazza P
    Life Sci; 1980 Sep; 27(13):1131-40. PubMed ID: 6252402
    [No Abstract]   [Full Text] [Related]  

  • 11. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.
    Dourish CT; Cooper SJ; Philips SR
    Psychopharmacology (Berl); 1985; 86(1-2):175-81. PubMed ID: 2991964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys.
    Woolverton WL
    Pharmacol Biochem Behav; 1986 Mar; 24(3):531-5. PubMed ID: 2871561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sedative action of low doses of dopaminergic agents.
    Maj J; Przewlocka B; Kukulka L
    Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates.
    Smith LA; Jackson MJ; Johnston L; Kuoppamaki M; Rose S; Al-Barghouthy G; Del Signore S; Jenner P
    Clin Neuropharmacol; 2006; 29(3):112-25. PubMed ID: 16772809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dopamine, apomorphine and piribedil on the mesenterial blood flow of the cat.
    György L; Dóda M
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):22-32. PubMed ID: 4026462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a dopaminergic agonist (piribedil) on cerebral blood flow in man.
    Güell A; Géraud G; Jauzac P; Victor G; Arné-Bès MC
    J Cereb Blood Flow Metab; 1982; 2(2):255-7. PubMed ID: 7076737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacology of piribedil].
    Marmo E
    Minerva Med; 1976 May; 67(25):1628-47. PubMed ID: 934518
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice.
    Anlezark GM; Meldrum BS
    Br J Pharmacol; 1975 Mar; 53(3):419-21. PubMed ID: 1173346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent dissociable effects of haloperidol on locomotion, appetitive responses, and consummatory behavior in water-deprived rats.
    Huang AC; Shyu BC; Hsiao S
    Pharmacol Biochem Behav; 2010 May; 95(3):285-91. PubMed ID: 20153357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.